Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Hasson

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Molecular Cancer Research : MCR|February 5, 2025
ATAD2 Drives Prostate Cancer Progression to MetastasisAnindita Dutta, Antonio Rodriguez-Calero, Kacey Ronaldson-Bouchard, et al.
JCI Insight|February 6, 2024
Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiationKaren Mendelson, Tiphaine C Martin, Christie B Nguyen, et al.
Cell Reports|April 6, 2022
Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanomaSaul Carcamo, Christie B Nguyen, Elena Grossi, et al.
Nature Communications|August 26, 2018
SIRT6 haploinsufficiency induces BRAF<sup>V600E</sup> melanoma cell resistance to MAPK inhibitors via IGF signallingThomas Strub, Flavia G Ghiraldini, Saul Carcamo, et al.
Cell Reports. Medicine|December 10, 2024
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancerSubhamoy Chakraborty, Utsav Sen, Kedwin Ventura, et al.
Cell Reports. Medicine|January 19, 2025
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancerSubhamoy Chakraborty, Utsav Sen, Kedwin Ventura, et al.
The Journal of Clinical Investigation|June 14, 2022
Disrupting the DREAM complex enables proliferation of adult human pancreatic β cellsPeng Wang, Esra Karakose, Carmen Argmann, et al.
Cancer Discovery|September 7, 2023
p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 ExpressionGizem Efe, Karen J Dunbar, Kensuke Sugiura, et al.
Molecular Cell|November 18, 2017
Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival GeneBarbara Fontanals-Cirera, Dan Hasson, Chiara Vardabasso, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
A Mutation-driven oncofetal regression fuels phenotypic plasticity in colorectal cancerSlim Mzoughi, Megan Schwarz, Xuedi Wang, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Molecular Cancer Research : MCR|February 5, 2025
ATAD2 Drives Prostate Cancer Progression to MetastasisAnindita Dutta, Antonio Rodriguez-Calero, Kacey Ronaldson-Bouchard, et al.
JCI Insight|February 6, 2024
Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiationKaren Mendelson, Tiphaine C Martin, Christie B Nguyen, et al.
Cell Reports|April 6, 2022
Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanomaSaul Carcamo, Christie B Nguyen, Elena Grossi, et al.
Nature Communications|August 26, 2018
SIRT6 haploinsufficiency induces BRAF<sup>V600E</sup> melanoma cell resistance to MAPK inhibitors via IGF signallingThomas Strub, Flavia G Ghiraldini, Saul Carcamo, et al.
Cell Reports. Medicine|December 10, 2024
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancerSubhamoy Chakraborty, Utsav Sen, Kedwin Ventura, et al.
Cell Reports. Medicine|January 19, 2025
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancerSubhamoy Chakraborty, Utsav Sen, Kedwin Ventura, et al.
The Journal of Clinical Investigation|June 14, 2022
Disrupting the DREAM complex enables proliferation of adult human pancreatic β cellsPeng Wang, Esra Karakose, Carmen Argmann, et al.
Cancer Discovery|September 7, 2023
p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 ExpressionGizem Efe, Karen J Dunbar, Kensuke Sugiura, et al.
Molecular Cell|November 18, 2017
Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival GeneBarbara Fontanals-Cirera, Dan Hasson, Chiara Vardabasso, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
A Mutation-driven oncofetal regression fuels phenotypic plasticity in colorectal cancerSlim Mzoughi, Megan Schwarz, Xuedi Wang, et al.
Pageof 10